Spiderwort Biotechnologies Inc.

A tissue engineering company specializing in the development of transformative biomaterial platforms for regenerative medicine

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

Today, Spiderwort Biotechnologies Inc. proudly marks 10 years of innovation.

Since our founding in August 2015, what began as a bold vision for the potential of cellulose-based biomaterials has grown into a clinical-stage company.

Thank you.

https://t.co/T5cQZjIdxC

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

We're 1 month away from @IAmBiotech where we're covering 2 big areas of innovation

🦴 CelluBridge®, our plant-derived scaffold for spinal cord injury, peer-reviewed in @SciReports

💉CelluJuve®, our next-gen cellulose-based dermal filler, now @GovCanHealth ITA-authorized

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

It's been a busy start to the year in the lab. Our team has been heads down preparing for critical milestones. We're looking forward to sharing more updates in the coming weeks and the perfect chance to meet live with the team is just around the corner at @IAmBiotech, June 22-25.

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

Goodbye 2025. Hello 2026. This year we’re focused on advancing our mission through regulatory milestones, partnerships, & continuing the scientific work that supports the future of regenerative medicine. We’re excited for what’s ahead & grateful to grow alongside our community.

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

From engaging w/ peers at global events, crossing regulatory milestones, contributing research to @SciReports, & celebrating 10 years, 2025 has been an important year in our journey. Thank you to our team, collaborators, & community for continuing to move our mission fwd.

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

ICYMI: Research featuring several members of the @SpiderwortBio R&D team has been published in @SciReports. The peer-reviewed study shows how plant-derived scaffolds can promote neural tissue repair and motor recovery in a preclinical model. Learn more ↓

https://t.co/7B3fIgfdWJ

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

New peer-reviewed research — a collaboration between @spiderwortbio and @uOttawaScience — in Nature’s @SciReports demonstrates how plant-derived scaffolds can support neural repair and motor recovery in a preclinical SCI model. Learn more ↓

https://t.co/NrlapjAAkt

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

Cellulose is the most abundant natural polymer on Earth: renewable, biocompatible, & adaptable.

At @SpiderwortBio, we leverage its structural versatility to design scaffolds that mimic the body’s extracellular environment & support tissue regeneration.

https://t.co/pPCg77jbKh

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

We’re live at #BIOEurope2025 in Vienna! Our team is meeting with peers, researchers, and partners to advance our mission of transforming regenerative medicine through cellulose-based biomaterials. Follow along for updates from the conference floor.

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

Our proprietary tech uses cellulose-based biomaterials to engineer scaffolds. Why cellulose? Cellulose-based biomaterials are highly compatible with human tissue and hold the potential to support the rebuilding of healthy tissues.

https://t.co/pPCg77jJzP

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

Hello from @MedTechCon San Diego Day 3! We're taking in all the information on the industry's biggest themes — AI, patient engagement, global market access, M&A and much more. Book an on-site meeting with our team.

https://t.co/rQsaYpekV8

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

@CMCuerrier, CEO, @SpiderwortBio: The last ten years has been about proving what’s possible. The next decade is about bringing it to the practitioners and patients who need creative solutions to unmet medical needs.

Explore what's ahead.

https://t.co/T5cQZjIdxC

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

Behind major breakthroughs is the infra that makes it possible. Our collaboration with @CollegeLaCite has brought a clean room to life, accelerated development of biotech, and given us the chance to work with passionate researchers. Learn more.

https://t.co/pIDnsdYfAP

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

Touchdown in Europe.

Our cellulose-based platform is opening new doors in regenerative medicine. This week, we're in Vienna and Geneva meeting with strategic partners to explore the future of medical aesthetics.

[Andy Donovan @AndyDonovan64]

This is fantastic news for @SpiderwortBio, #lifesciences and healthcare in Canada (and beyond). Wishing you great success as you enter into human clinical trials here my friends. cc @LifeSciencesON @clinicaltrialON

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

@AndyDonovan64 @LifeSciencesON @clinicaltrialON We’re proud to be building the future of biomaterials right here in Canada 🍁🍎

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

In case you missed it... Big news via @obj_news: We've received @GovCanHealth approval to begin human clinical trials for #CelluJuve – our all-natural, cellulose-based alternative to legacy medical aesthetic treatment options.

https://t.co/ewT825M2w4

[Spiderwort Biotechnologies Inc. @SpiderwortBio]

Last week, Dr. Stephen Hanson shared an update on our spinal cord injury treatment progress using #CelluBridge and the Aerocell™ technology platform at the 3rd Annual @SciSymposium. Thank you to the organizers for creating this platform to explore the latest in #SCI treatment.

[SCI Investor Symposium @SciSymposium]

The @SCISymposium is happening now — discover how innovators are driving progress in spinal cord injury treatment. https://t.co/QsngvSem1w

Presenters include @LineageCell, @NervGenP, @NBiologic, @onwdempowered, @Paradromics, @SpiderwortBio, @synchroninc, @RUSHMedical, @Umiamimedicine, @RobertPaylor5, @KesslerFdn, and @AbilityLab.

Hosted by @LineageCell and @ReeveFoundation

#SCI #SpinalCordInjury #InvestorEvents | @HCWCO | @rwbaird | @CEO_Culley

[Lineage Cell Therapeutics @LineageCell]

We are 3 days away from the @SciSymposium hosted by @LineageCell and @ReeveFoundation

Investors can register and request their 1-on-1 meetings with participating companies: https://t.co/NjbQT7DL6g

Presenters include @LineageCell, @NervGenP, @NBiologic, @onwdempowered, @Paradromics @PrecisionNeuro_, @SpiderwortBio, @synchroninc, @RUSHMedical, @Umiamimedicine, @RobertPaylor5, @KesslerFdn, and @AbilityLab.

#SCI #SpinalCordInjury #InvestorEvents | @HCWCO | @rwbaird

[SCI Investor Symposium @SciSymposium]

We are 3 days away from the @SciSymposium hosted by @LineageCell and @ReeveFoundation

Investors can register and request their 1-on-1 meetings with participating companies: https://t.co/O4EL63jMtt

Presenters include @LineageCell, @NervGenP, @NBiologic, @onwdempowered, @Paradromics @PrecisionNeuro_, @SpiderwortBio, @synchroninc, @RUSHMedical, @Umiamimedicine, @RobertPaylor5, @KesslerFdn, and @AbilityLab.

#SCI #SpinalCordInjury #InvestorEvents | @HCWCO | @rwbaird